Bellerophon Therapeutics, Inc.·4

May 22, 7:32 AM ET

Bellerophon Therapeutics, Inc. 4

4 · Bellerophon Therapeutics, Inc. · Filed May 22, 2015

Insider Transaction Report

Form 4
Period: 2015-05-20
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2015-05-20$8.40/sh+712$5,98119,098 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -